Semaglutide and liraglutide linked to lower alcohol-related hospitalization risk
A recent study published in JAMA Psychiatry has uncovered promising evidence suggesting that glucagon-like peptide-1 (GLP-1) receptor agonists, particularly semaglutide and liraglutide, may be effective treatments for alcohol use disorder.…